|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 536.12 USD | +0.62% |
|
+12.12% | +10.03% |
| Capitalization | 23.35B 20.41B 18.44B 17.64B 32.09B 2,160B 33.35B 220B 87.3B 1,032B 87.63B 85.78B 3,727B | P/E ratio 2026 * |
18.9x | P/E ratio 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise value | 18.73B 16.37B 14.79B 14.15B 25.73B 1,732B 26.75B 177B 70.02B 828B 70.28B 68.79B 2,989B | EV / Sales 2026 * |
5.6x | EV / Sales 2027 * | 4.6x |
| Free-Float |
58.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: United Therapeutics Corporation
| 1 day | +0.62% | ||
| 1 week | +12.12% | ||
| Current month | +6.39% | ||
| 1 month | +13.19% | ||
| 3 months | +7.16% | ||
| 6 months | +33.00% | ||
| Current year | +10.03% |
| 1 week | 495.5 |  | 548.12 |
| 1 month | 466 | | 548.12 |
| Current year | 455.63 | | 548.12 |
| 1 year | 266.98 | | 548.12 |
| 3 years | 204.44 | | 548.12 |
| 5 years | 155.86 | | 548.12 |
| 10 years | 74.31 | | 548.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 1996-06-25 | |
| President | 54 | 2016-06-25 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 2015-03-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 2001-12-31 |
| Chairman | 71 | 1996-06-25 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 2001-12-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 3.06% | 1 M€ | |
| 0.00% | 2.87% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.62% | +12.12% | +75.55% | +138.57% | 23.35B | |
| +0.80% | -0.53% | +22.88% | +203.58% | 873B | |
| -0.21% | +0.47% | +48.18% | +57.79% | 583B | |
| -2.52% | -4.53% | +3.84% | +44.57% | 398B | |
| +0.79% | -8.76% | +4.36% | +21.64% | 324B | |
| +0.11% | -2.67% | +23.43% | +34.42% | 297B | |
| +0.43% | -2.77% | +26.01% | +62.64% | 294B | |
| -0.26% | -0.16% | +22.07% | +9.34% | 287B | |
| -0.43% | -0.90% | +17.13% | +57.05% | 198B | |
| +0.42% | +0.74% | +27.91% | +82.35% | 180B | |
| Average | +0.17% | -0.82% | +27.14% | +71.20% | 345.87B | |
| Weighted average by Cap. | +0.27% | -1.67% | +23.75% | +85.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.34B 2.92B 2.64B 2.53B 4.59B 309B 4.78B 31.55B 12.5B 148B 12.55B 12.28B 534B | 3.78B 3.31B 2.99B 2.86B 5.2B 350B 5.4B 35.69B 14.14B 167B 14.19B 13.89B 604B |
| Net income | 1.33B 1.17B 1.05B 1.01B 1.83B 123B 1.91B 12.59B 4.99B 58.96B 5.01B 4.9B 213B | 1.55B 1.36B 1.23B 1.17B 2.13B 143B 2.22B 14.63B 5.8B 68.55B 5.82B 5.7B 248B |
| Net Debt | -4.62B -4.04B -3.65B -3.49B -6.35B -428B -6.6B -43.62B -17.29B -204B -17.35B -16.98B -738B | -5.94B -5.19B -4.69B -4.48B -8.16B -549B -8.48B -56.01B -22.2B -262B -22.28B -21.81B -948B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-13 | 536.12 $ | +0.62% | 526,884 |
| 26-03-12 | 532.82 $ | -2.18% | 622,175 |
| 26-03-11 | 544.71 $ | +1.66% | 1,477,201 |
| 26-03-10 | 535.81 $ | +1.25% | 785,715 |
| 26-03-09 | 529.17 $ | +10.67% | 1,155,655 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
